Shandong Sinobioway Biomedicine Co., Ltd. (SHE:002581)
China flag China · Delayed Price · Currency is CNY
8.32
+0.09 (1.09%)
At close: Mar 10, 2026

SHE:002581 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2019 - 2015
Cash & Equivalents
325.3506.4151.91183.8187.8284.15
Upgrade
Cash & Short-Term Investments
325.3506.4151.91183.8187.8284.15
Upgrade
Cash Growth
-24.14%233.35%-17.35%-2.13%-33.91%-74.65%
Upgrade
Accounts Receivable
199.4793.32172.62179.72272.96353.77
Upgrade
Other Receivables
113.4252.2478.8718.3613.4916.75
Upgrade
Receivables
312.89145.55251.49198.09286.45370.52
Upgrade
Inventory
127.3279.6485.3180.0464.3370.87
Upgrade
Other Current Assets
19.3515.417.9956.4329.8840.62
Upgrade
Total Current Assets
784.85747.01496.71518.36568.45766.16
Upgrade
Property, Plant & Equipment
325.51274.74357.84705.47713.76684.72
Upgrade
Long-Term Investments
936.411,0561,3551,5031,223751.21
Upgrade
Other Intangible Assets
97.893.47108.29126.32134.29144.55
Upgrade
Long-Term Deferred Tax Assets
21.3711.216.1211.8425.2825.14
Upgrade
Long-Term Deferred Charges
0.210.321.415.27.787.72
Upgrade
Other Long-Term Assets
48.4713.4412.260.4983.3665.46
Upgrade
Total Assets
2,2152,1962,3372,8702,7562,445
Upgrade
Accounts Payable
83.5835.3573.6943.6442.1314.46
Upgrade
Accrued Expenses
7.9620.8322.519.3231.0132.34
Upgrade
Short-Term Debt
37.532.7713.84150.42151.54118.5
Upgrade
Current Portion of Leases
21.730.17-13.4615.8320.82
Upgrade
Current Income Taxes Payable
2.56-0.951.20.440.65
Upgrade
Current Unearned Revenue
1.0510.463.5926.863.431.21
Upgrade
Other Current Liabilities
32.5313.0319.03109.3814.1718.9
Upgrade
Total Current Liabilities
186.9482.61133.61364.28258.54206.87
Upgrade
Long-Term Debt
8.51-----
Upgrade
Long-Term Leases
3.07-0.711.479.827.77
Upgrade
Long-Term Unearned Revenue
5.495.495.496.719.7410.96
Upgrade
Long-Term Deferred Tax Liabilities
9.789.397.517.688.688.74
Upgrade
Other Long-Term Liabilities
7.7276.1216.099.67--
Upgrade
Total Liabilities
221.51173.61163.41389.82286.76254.33
Upgrade
Common Stock
229.15229.15229.15229.15229.15229.15
Upgrade
Additional Paid-In Capital
880.95866.41873.93858.5858.29858.29
Upgrade
Retained Earnings
759.27828.08965.391,2981,3011,030
Upgrade
Total Common Equity
1,8691,9242,0682,3852,3882,117
Upgrade
Minority Interest
123.7498.67105.2694.9481.1173.43
Upgrade
Shareholders' Equity
1,9932,0222,1742,4802,4692,191
Upgrade
Total Liabilities & Equity
2,2152,1962,3372,8702,7562,445
Upgrade
Total Debt
70.842.9414.55165.35177.16167.09
Upgrade
Net Cash (Debt)
254.46503.47137.3618.4510.64117.06
Upgrade
Net Cash Growth
-40.63%266.52%644.38%73.50%-90.91%-43.55%
Upgrade
Net Cash Per Share
0.390.760.210.030.020.18
Upgrade
Filing Date Shares Outstanding
659.56659.74659.74659.74659.74659.74
Upgrade
Total Common Shares Outstanding
659.56659.74659.74659.74659.74659.74
Upgrade
Working Capital
597.91664.4363.1154.08309.91559.3
Upgrade
Book Value Per Share
2.832.923.143.623.623.21
Upgrade
Tangible Book Value
1,7721,8301,9602,2592,2541,973
Upgrade
Tangible Book Value Per Share
2.692.772.973.423.422.99
Upgrade
Buildings
-393.55486.08639.62612.92426.35
Upgrade
Machinery
-431.4432.25413.16424.47345.34
Upgrade
Construction In Progress
-38.1122.1791.4364.86353.63
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.